Last reviewed · How we verify

NCT02337465

KV-CBCT and Ultrasound Imaging in Guiding Radiation Therapy in Patients With Prostate, Liver, or Pancreatic Cancer

Completed NA Results posted Last updated 23 February 2021
What this trial tests

NA trial testing Cone-Beam Computed Tomography in Adult Liver Carcinoma in 30 participants. Completed in 14 December 2019.

Timeline
22 September 2015
Primary endpoint
14 December 2019
14 December 2019

Quick facts

Lead sponsorCase Comprehensive Cancer Center
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment30
Start date22 September 2015
Primary completion14 December 2019
Estimated completion14 December 2019
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Case Comprehensive Cancer Center — full company profile →

Who can join

19 and older, any sex, with Adult Liver Carcinoma or Malignant Pancreatic Neoplasm. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Percentage of Ultrasound Images Which Are Clinically Adequate for Treatment Set-up Primary · Up to 1 year

Percentage of ultrasound images which are clinically adequate for treatment set-up in the judgment of the treating physician

GroupValue95% CI
Diagnostic (KV-CBCT, Ultrasound-guided Radiation Therapy)100
Number of Participants Able to Have the Ultrasound Probe Attached During the Entire Treatment Course Primary · Up to 1 year

Proportion of participants able to have the ultrasound probe attached during the entire treatment course

GroupValue95% CI
Diagnostic (KV-CBCT, Ultrasound-guided Radiation Therapy)29
Percent of Patients Whose Plan Quality Was Not Not Affected in the Presence of the Ultrasound Probe Primary · Up to 1 year

Quality of plans for patients not affected in the presence of the ultrasound probe, defined as no more than a 2% decrease in tumor coverage, and also no more than a 2% increase in the dose to the most critical normal tissue for that tumor location

GroupValue95% CI
Diagnostic (KV-CBCT, Ultrasound-guided Radiation Therapy)100

Sponsor's own description

This clinical trial studies if kilo-voltage cone beam computed tomography (KV-CBCT) and ultrasound imaging works in guiding radiation therapy in patients with prostate, liver, or pancreatic cancer. Computer systems, such as KV-CBCT and ultrasound imaging, allow doctors to create a 3-dimensional picture of the tumor may help in planning radiation therapy and may result in more tumor cells being killed.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Cone-Beam Computed Tomography

Trials testing the same drug.

Other Case Comprehensive Cancer Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02337465.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing